Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

This study is testing whether a treatment using mesenchymal stem cells (special cells from the body that can influence the immune system) can help preserve insulin production in people newly diagnosed with Type 1 diabetes. In Type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas; this treatment aims to slow or stop that process. **You may be eligible if...** - You have been diagnosed with Type 1 diabetes within the last 6 months - You are between 18 and 40 years old - You still have some remaining insulin production (shown by a specific blood test called C-peptide) - You have at least one diabetes-related antibody in your blood (such as GAD, IA-2, or ZnT8) - You are willing to follow an intensive diabetes management plan - You are mentally stable and able to follow the study protocol **You may NOT be eligible if...** - You have had Type 1 diabetes for more than 6 months before enrolling - You do not have measurable remaining insulin production - You are unwilling to comply with the study's management and visit schedule Talk to your doctor to see if this trial is right for you.